好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2008 Annual Meeting | Poster Session 05

Wednesday 04/16/08
04:00 PM - 07:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Movement Disorders, Neuro-oncology, Infections/AIDS/Prion Disease, Neuro-ophthalmology/Neuro-otology, MS and Related Diseases, Aging and Dementia, Behavioral Neurology, Sleep, Headache/Other Pain Syndromes, Headache
No CME available
Event Timeline
04:00 PM - 07:00 PM Abstract 001 - Prevalence and Risk Factors of HIV Encephalopathy in Adult Malawians
04:00 PM - 07:00 PM Abstract 002 - HIV-Associated Strokes in Minority Patients in an Inner City Teaching Hospital: Retrospective Data Analysis
04:00 PM - 07:00 PM Abstract 003 - Gonadal Hormone Dysfunction and HIV-Associated Neurocognitive Disorders in Women
04:00 PM - 07:00 PM Abstract 004 - Cortical Direct Current Stimulation for the Treatment of Minor Depression in HIV-Positive Persons
04:00 PM - 07:00 PM Abstract 005 - Correlates of HIV Sensory Neuropathy in a Puerto Rican Cohort
04:00 PM - 07:00 PM Abstract 006 - Peripheral Neuropathy in HIV Positive Zambian Adults Is Not Due to Micronutrient Deficiency or Derangements of Tryptophan Metabolism
04:00 PM - 07:00 PM Abstract 007 - Mitochondrial Oxidative Stress and Painful Peripheral Neuropathy in HIV Infection
04:00 PM - 07:00 PM Abstract 008 - NeuroIRIS in HIV Infection: Clinical and Epidemiological Aspects
04:00 PM - 07:00 PM Abstract 009 - Modulation of In Vivo T Cell Activation by an Acetylcholine-Esterase Inhibitor in Patients Chronically Infected with HIV
04:00 PM - 07:00 PM Abstract 010 - Determination of the Source of Increased Cerebrospinal Fluid Immunoglobulins in Human Immunodeficiency Virus Seropositive Patients
04:00 PM - 07:00 PM Abstract 011 - Transplant-Associated Transmission of West Nile Neuroinvasive Disease
04:00 PM - 07:00 PM Abstract 012 - Knowledge, Attitude and Perceptions about Tetanus and Rabies; a Population Based Survey from Karachi, Pakistan
04:00 PM - 07:00 PM Abstract 013 - Progressive MRI Abnormalities in Human Rabies Encephalomyelitis
04:00 PM - 07:00 PM Abstract 014 - Dengue Fever as a Cause of Benign Acute Chilhood Viral Myositis
04:00 PM - 07:00 PM Abstract 015 - Chikungunya Fever Epidemic in South India: Neurological Complications
04:00 PM - 07:00 PM Abstract 016 - Following the Stages of Herpes Simplex Virus Type 1 (HSV-1) Infection of Mice Brain in Organotypic Cultures
04:00 PM - 07:00 PM Abstract 017 - A Binding Partner of L Protein of Theiler's Murine Encephalomyelitis Virus (TMEV) and Its Potential Role in Virus Persistence
04:00 PM - 07:00 PM Abstract 018 - Neurological Impairment and Disability in HTLV-1 Associated Myelopathy Patients
04:00 PM - 07:00 PM Abstract 019 - Amyotrophic Lateral Sclerosis (ALS) Syndrome Associated to HTLV-I Virus Infection
04:00 PM - 07:00 PM Abstract 020 - Pattern of CNS AIDS at the Fevers Unit, KBTH over 1 Year
04:00 PM - 07:00 PM Abstract 021 - Immune Reconstitution Inflammatory Syndrome in a Patient with AIDS and Cerebral Toxoplasmosis: A Case Report
04:00 PM - 07:00 PM Abstract 022 - Spinal Cord Toxoplasmosis as an Unusual Presentation for AIDS Diagnosis: Case Report and Review
04:00 PM - 07:00 PM Abstract 023 - Diagnosis and Outcome of Progressive Multifocal Leukoencephalopathy (PML) at an Urban Public Hospital
04:00 PM - 07:00 PM Abstract 024 - Systemic Nocardiosis with Multiple Brain Abscesses in a Rheumatoid Arthritis Recipient Treated with TNF Blockers and Successfully Treated with Antibiotics Alone
04:00 PM - 07:00 PM Abstract 025 - Weight Gain and Recurrence in Idiopathic Intracranial Hypertension (IIH)
04:00 PM - 07:00 PM Abstract 026 - Rare Mitochondrial DNA Point Mutations Pathogenic for Leber Hereditary Optic Neuropathy
04:00 PM - 07:00 PM Abstract 027 - Familial Clustering in Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
04:00 PM - 07:00 PM Abstract 028 - Visual Field Deficits Following Temporal Lobe Epilepsy Surgery: A Long Term Follow-Up and Prognostic Implications
04:00 PM - 07:00 PM Abstract 029 - Chronic Relapsing Inflammatory Optic Neuritis (CRION): Is It Neuromyelitis Optica?
04:00 PM - 07:00 PM Abstract 030 - Purtscher's Retinopathy in a Postpartum Patient with Hypertensive Encephalopathy
04:00 PM - 07:00 PM Abstract 031 - Retinal Nerve Fiber Layer Assessed by OCT in Different Forms of Multiple Sclerosis
04:00 PM - 07:00 PM Abstract 032 - Cortical Blindness Following Fludarabine Therapy: A Case Report and Review of Literature
04:00 PM - 07:00 PM Abstract 033 - Retrospective Evaluation of Optic Neuritis in African American Patients
04:00 PM - 07:00 PM Abstract 034 - Optical Coherence Tomography in Neuromyelitis Optica
04:00 PM - 07:00 PM Abstract 035 - Epley's Manoeuvre for Benign Paroxysmal Positional Vertigo: A Prospective Study
04:00 PM - 07:00 PM Abstract 036 - Topiramate in Patients with Migraine Associated Recurrent Vertigo
04:00 PM - 07:00 PM Abstract 037 - Novel Role of Greater Occipital Nerve Trigger Point Injections in a Sub-Set of Tinnitus Patients
04:00 PM - 07:00 PM Abstract 038 - Unnecessary High Costs in the Evaluation of Benign Paroxysmal Positional Vertigo
04:00 PM - 07:00 PM Abstract 039 - Chronic Tinnitus: A Neurological Problem
04:00 PM - 07:00 PM Abstract 040 - Neuro-Otologic Abnormalities in Patients with Fabry Disease
04:00 PM - 07:00 PM Abstract 041 - Combined Horizontal and Vertical One-and-A-Half Syndrome (OAHS) Due to Antiphospholipid Syndrome
04:00 PM - 07:00 PM Abstract 042 - Neuro-Ophthalmic Findings That May Reliably Differentiate Progressive Supranuclear Palsy and Parkinson's Disease
04:00 PM - 07:00 PM Abstract 043 - Ocular Motor Anatomy in Interrupted Saccades
04:00 PM - 07:00 PM Abstract 044 - Is IGT a Risk Factor for Idiopathic Ophthalmoplegia?
04:00 PM - 07:00 PM Abstract 045 - MRI Volumetric Studies of Cerebellar Atrophy in Late-Onset Tay-Sachs Disease (LOTS)
04:00 PM - 07:00 PM Abstract 046 - Quadrant-Specific Retinal Nerve Fiber Layer Thinning by Optical Coherence Tomography (OCT) in MS
04:00 PM - 07:00 PM Abstract 047 - Retinal Nerve Fibre Layer Axonal Loss Following Unilateral Acute Optic Neuritis
04:00 PM - 07:00 PM Abstract 048 - Diffusion Tensor MRI and Optical Coherence Tomography as Measures of Anterior Visual Pathway Integrity in MS
04:00 PM - 07:00 PM Abstract 049 - Retinal Nerve Fiber Layer Thickness Is Associated with Proton Magnetic Resonance Spectroscopy Measures and Brain Atrophy in Multiple Sclerosis
04:00 PM - 07:00 PM Abstract 050 - Does Chronic Optic Neuritis Exist in Multiple Sclerosis?
04:00 PM - 07:00 PM Abstract 051 - Retinal Atrophy Using Optical Coherence Tomography in 94 Patients with Multiple Sclerosis and Comparison with Healthy Subjects
04:00 PM - 07:00 PM Abstract 052 - Neuromyelitis Optica Treated with Mycophenolate: Retrospective Analysis of 25 Cases
04:00 PM - 07:00 PM Abstract 053 - Is Neuromyelitis Optica Associated with HLA?
04:00 PM - 07:00 PM Abstract 054 - Familial Neuromyelitis Optica
04:00 PM - 07:00 PM Abstract 055 - Sj[ouml]gren Myelopathy and Neuromyelitis Optica
04:00 PM - 07:00 PM Abstract 056 - Distinct Immunological Features Compared between Anti-Aquaporin-4 Antibody-Positive and -Negative Opticospinal Japanese Multiple Sclerosis Patients
04:00 PM - 07:00 PM Abstract 057 - Devic's Neuromyelitis Optica: An Analysis of 47 Patients and Prognostic Implications of NMO IgG Status
04:00 PM - 07:00 PM Abstract 058 - A Western Blot and Immunoprecipitation Method To Detect Anti-NMO IgG and Anti-AQP4 Antibodies in the Serum of Patients with Neuromyelitis Optica
04:00 PM - 07:00 PM Abstract 059 - Fatigue Is Less Prominent in Neuromyelitis Optica Than in Multiple Sclerosis: Pathophysiological Implications
04:00 PM - 07:00 PM Abstract 060 - Spinal Stenosis Leads to Misdiagnosis of Transverse Myelitis
04:00 PM - 07:00 PM Abstract 061 - Neuromyelitis Optica and Celiac Disease
04:00 PM - 07:00 PM Abstract 062 - Brain Abnormalities of Neuromyelitis Optica in China
04:00 PM - 07:00 PM Abstract 063 - Blood Brain Barrier (BBB) Impairment in NMO-IgG Seropositive Patients: An Aquaporine-4 (AQP-4) Related Damage?
04:00 PM - 07:00 PM Abstract 064 - Development of Extensive Brain Lesions Following Interferon-beta Therapy in Relapsing Neuromyelitis Optica and Longitudinally Extensive Myelitis with Anti-Aquaporin-4 Antibody
04:00 PM - 07:00 PM Abstract 065 - Impact of Natalizumab on Multiple Sclerosis Patient-Reported Experiences: A Cross Sectional Survey
04:00 PM - 07:00 PM Abstract 066 - The Optometric Correlates of Multiple Sclerosis
04:00 PM - 07:00 PM Abstract 067 - A New Severity-Based Classification System for Multiple Sclerosis
04:00 PM - 07:00 PM Abstract 068 - Cognitive Presentation in Multiple Sclerosis (MS)
04:00 PM - 07:00 PM Abstract 069 - Multiple Sclerosis - Effects of Immunomodulatory Therapy on Pregnancy Outcome - A Clinical Study - Preliminary Results
04:00 PM - 07:00 PM Abstract 070 - The Modified Rankin Score, EDSS and MRI Measures Using CombiRx Baseline Assessments
04:00 PM - 07:00 PM Abstract 071 - Resistance Training Reduces Fatigue and Depression in Patients with Multiple Sclerosis - Preliminary Data from an Ongoing Study
04:00 PM - 07:00 PM Abstract 072 - Quality of Life in Patients with Multiple Sclerosis: The Impact of Cognitive Deficit and Fatigue
04:00 PM - 07:00 PM Abstract 073 - Does Adherence to Disease Modifying Agents Influence Quality of Life in Patients with Multiple Sclerosis?
04:00 PM - 07:00 PM Abstract 074 - Robot Training Protocol for Cerebellar Multiple Sclerosis Subjects: A Double Blind Randomised Cross-Over Study
04:00 PM - 07:00 PM Abstract 075 - Association between Treatment Compliance and Severe Relapses for Multiple Sclerosis Patients Receiving Disease-Modifying Drugs: Findings from a National Managed Care Database
04:00 PM - 07:00 PM Abstract 076 - Examination of Quality of Life in RRMS Patients during the First Year of Treatment with Interferon beta-1a (IM)
04:00 PM - 07:00 PM Abstract 077 - Regression Modeling of T2 Lesion Volume in Patients with a Clinically Isolated Syndrome at High Risk - A Pooled Data Analysis
04:00 PM - 07:00 PM Abstract 078 - Characterization of the Affinity Maturation of the Immune Response Against IFNb Using Surface Plasmon Resonance (Biacore[trade])
04:00 PM - 07:00 PM Abstract 079 - The Cross-Reactivity of the Neutralizing Antibodies (NAbs) to the Different Interferons (IFN) Used To Treat Multiple Sclerosis Is Very Far from Complete and This Has Major Clinical Relevance for Defining Positivity and High Titers
04:00 PM - 07:00 PM Abstract 080 - Validation of a Luciferase Reporter Gene Assay Against the Standard Cytopathic Effect Assay (CPE) for Neutralizing Antibodies (NAbs) to Interferon Beta (IFN-B) in IFN-B Treated Multiple Sclerosis Patients
04:00 PM - 07:00 PM Abstract 081 - High Dose Intravenous Interferon-beta in MS Patients with Neutralizing Antibodies (HINABS) - A Pilot Study
04:00 PM - 07:00 PM Abstract 082 - Evaluation of 4 Different Assays To Determine Antibodies to Interferon-beta
04:00 PM - 07:00 PM Abstract 083 - An Association between Serum Apolipoprotein E Levels and Anti-Interferon-[beta] Neutralizing Antibodies in Multiple Sclerosis
04:00 PM - 07:00 PM Abstract 084 - Incidence of Binding and Neutralizing Antibodies in Sera and Cerebrospinal Fluid of Patients with Relapsing-Remitting Multiple Sclerosis Treated with Interferon Beta
04:00 PM - 07:00 PM Abstract 085 - Clinico-Pathological Correlations of Perivenous Versus Confluent Demyelination in Acute Inflammatory Demyelinating Disease
04:00 PM - 07:00 PM Abstract 086 - EEG Abnormalities in Patients with Multiple Sclerosis
04:00 PM - 07:00 PM Abstract 087 - Evidence for Small Fiber Neuropathy in Multiple Sclerosis
04:00 PM - 07:00 PM Abstract 088 - Mitochondrial DNA Deletions Accumulate in the Brain Related to Aging but Not to the Pathology of Multiple Sclerosis
04:00 PM - 07:00 PM Abstract 089 - Dermatomal Somatosensory Evoked Potentials (DSEPs) Can Identify Lumbosacral Spinal Stenosis (LSSS) in Patients with Multiple Sclerosis (MS)
04:00 PM - 07:00 PM Abstract 090 - Lhermitte's Sign in Multiple Sclerosis: Neuroradiological Correlation
04:00 PM - 07:00 PM Abstract 091 - The Neuroanatomical Correlates of Abnormal Behavior in Frontotemporal Dementia
04:00 PM - 07:00 PM Abstract 092 - Progranulin Capillary Length-Density Is Reduced in Alzheimer's Disease (AD) Hippocampus: A Role for Aberrant Wound Healing and Angiogenesis in the Pathogenesis of AD
04:00 PM - 07:00 PM Abstract 093 - Spongiform Change in Lewy Body Dementia and Alzheimer's Disease
04:00 PM - 07:00 PM Abstract 094 - Clinicopathological Case Comparison: Familial Frontotemporal Lobar Degeneration-Motor Neuron Disease with Phenotypic Heterogeneity in Two First-Degree Relatives
04:00 PM - 07:00 PM Abstract 095 - An Extended Analysis of the Histological Variants of Tau-Negative Frontotemporal Lobar Degeneration
04:00 PM - 07:00 PM Abstract 096 - An Association between Lewy Body Pathology and Cerebral Atherosclerosis
04:00 PM - 07:00 PM Abstract 097 - Dementia with Lewy Bodies (DLB), Parkinson's Disease Dementia (PDD) and Alzheimer Dementia (AD): A Retrospective Clinical Comparison and Quantitative Neuropathologic Study
04:00 PM - 07:00 PM Abstract 098 - Effect of Age on the Distribution of Tau Immunoreactivity in Alzheimer's Disease
04:00 PM - 07:00 PM Abstract 099 - Postmortem Stability of Alzheimer's Disease-Associated Proteins
04:00 PM - 07:00 PM Abstract 100 - Butyrylcholinesterase (BuChE) Expression as a Marker of Endangerment of Cortical Neurons in Early Alzheimer's Disease (AD)
04:00 PM - 07:00 PM Abstract 101 - A Plasma Panel of Nutrient Biomarkers Is More Reliable Than Food Frequency Questionnaire in MCI Subjects
04:00 PM - 07:00 PM Abstract 102 - Degraded Temporal Integration in the Aging Primary Auditory Cortex
04:00 PM - 07:00 PM Abstract 103 - Diet, Exercise and Alzheimer's Disease Risk
04:00 PM - 07:00 PM Abstract 104 - Cognitive Reserve Mediates Amyloid-Related Cognitive Impairment
04:00 PM - 07:00 PM Abstract 105 - Endogenous Sex Hormones, Testosterone, Dehydroepiandrosterone-Sulfate (DHEAS) and Estradiol, and Cognition: Results from the Einstein Aging Study
04:00 PM - 07:00 PM Abstract 106 - Cognitive Correlates of Poor Navigation in Cognitively-Normal Older Adults
04:00 PM - 07:00 PM Abstract 107 - A Comparison of Cognitive Reserve Markers for Predicting Rates of Memory Decline in Preclinical Alzheimer's Disease
04:00 PM - 07:00 PM Abstract 108 - Assessment of Autobiographical Memory in Mild Cognitive Impairment
04:00 PM - 07:00 PM Abstract 109 - Components of Episodic Memory: Relationship to Cognitive Decline and Cognitive Reserve
04:00 PM - 07:00 PM Abstract 110 - Non-Verbal Memory Performance Is Associated with Conversion to Dementia within 1 Year: A Prospective Study of MCI Using Computerized Cognitive Assessment
04:00 PM - 07:00 PM Abstract 111 - Context Processing and Stroop Deficits in Normal Aging Are Explained by White Matter Hyperintensities
04:00 PM - 07:00 PM Abstract 112 - Performance on an Alzheimer-Selective Odor Identification Test in Patients with Parkinson Disease
04:00 PM - 07:00 PM Abstract 113 - Memory Performance Is Related to Amyloid and Tau Pathology in the Hippocampus
04:00 PM - 07:00 PM Abstract 114 - Cued and Free Recall Verbal Memory Low Performance Predicts Dementia in the 3C Population-Based Study
04:00 PM - 07:00 PM Abstract 115 - A Comparison of Cognitive Structure in Healthy Controls, Parkinson Disease with and without Dementia and Alzheimer Disease
04:00 PM - 07:00 PM Abstract 116 - Clock Drawing: Quantitative and Qualitative Analysis of 131 AD Subjects
04:00 PM - 07:00 PM Abstract 117 - RAVLT as an Instrument for the Early Diagnosis of Alzheimer Disease
04:00 PM - 07:00 PM Abstract 118 - Fear Conditioning in Frontotemporal Lobar Degeneration and Alzheimer's Disease
04:00 PM - 07:00 PM Abstract 119 - Apolipoprotein E and Cognitive Systems in Older Blacks and Whites
04:00 PM - 07:00 PM Abstract 120 - A Randomized Controlled Trial of Clock Drawing Test Scoring by Behavioral Neurologists
04:00 PM - 07:00 PM Abstract 121 - Longitudinal Analyses of Cognition in Dementia of the Alzheimer Type, Parkinson's Patients with and without Dementia, and Healthy Controls
04:00 PM - 07:00 PM Abstract 122 - Frontal Systems Behavior Scale in Dementia Syndromes
04:00 PM - 07:00 PM Abstract 123 - Cognitive Function Assessment in Normal Brazilian Elders: Different Profile Results Regarding to Age and Higher 好色先生al Level
04:00 PM - 07:00 PM Abstract 124 - Anatomy, Neuropsychology, and Behavior in a Series of 14 Autopsy-Proven Corticobasal Degeneration Patients
04:00 PM - 07:00 PM Abstract 125 - Mild Behavioural Impairment (MBI) and Risk of Dementia
04:00 PM - 07:00 PM Abstract 126 - Fenofibrate Has a Disease Modifier Effect in the MPTP Mouse Model of Parkinson's Disease
04:00 PM - 07:00 PM Abstract 127 - Risk Factors for Transitions from Mild Cognitive Impairment to Dementia: Evidence from Cognitive Reserve
04:00 PM - 07:00 PM Abstract 128 - Normative Data for the Montreal Cognitive Assessment (MoCA) in Young Adults
04:00 PM - 07:00 PM Abstract 129 - Validity and Reliability of the SF-36 Administered to Caregivers of Patients with Alzheimer's Disease
04:00 PM - 07:00 PM Abstract 130 - Elucidating the Organizational Structure of Scripts - Evidence from Frontotemporal Dementia
04:00 PM - 07:00 PM Abstract 131 - Memory Impairment Screen (MIS) Normative Data and Discriminative Validity: Argentine Version
04:00 PM - 07:00 PM Abstract 132 - The Relationship between Physical Performance and Cognitive Status in Lewy Body Dementia
04:00 PM - 07:00 PM Abstract 133 - Prevalence of Cobalamin (Vitamin B12) Deficiency in a Demented Population
04:00 PM - 07:00 PM Abstract 134 - A Double-Blind, Placebo-Controlled, Dose-Escalation Trial of Pimavanserin in Parkinson's Disease and Psychosis
04:00 PM - 07:00 PM Abstract 135 - Cerebral Glucose Metabolic Changes in Parkinson Disease Patients with Visual Hallucinations
04:00 PM - 07:00 PM Abstract 136 - A Questionnaire-Based (UM-PDHQ) Study of Hallucinations in Parkinson's Disease
04:00 PM - 07:00 PM Abstract 137 - Cingulate Atrophy Predicts Mild Cognitive Impairment in Early Parkinson Disease. A Voxel Based Morphometry Study
04:00 PM - 07:00 PM Abstract 138 - Hippocampal Atrophy in Parkinson's Disease Patients with Mild Cognitive Impairment
04:00 PM - 07:00 PM Abstract 139 - The Relationship between Cognitive Functioning and Whole Brain Diffusion Tensor Imaging Abnormalities in Parkinson's Disease
04:00 PM - 07:00 PM Abstract 140 - The Relationship between Diffusion Tensor Tractography and Cognitive Functioning in Parkinson's Disease
04:00 PM - 07:00 PM Abstract 141 - Does Laterality of Motor Impairment Tell Us Something about Cognition in Parkinson Disease?
04:00 PM - 07:00 PM Abstract 142 - A Comparison of Two Brief Cognitive Screening Instruments in Parkinson's Disease (PD)
04:00 PM - 07:00 PM Abstract 143 - Non-Specific Motor and Cognitive Changes in Incidental Lewy Body Disease
04:00 PM - 07:00 PM Abstract 144 - Detecting Depression in Parkinson's Disease: How Useful Is the Unified Parkinson Disease Rating Scale?
04:00 PM - 07:00 PM Abstract 145 - PRODEST - Depressive Symptoms in Parkinson's Disease: Effect of Antidepressant Treatment on Symptom Items of Depression
04:00 PM - 07:00 PM Abstract 146 - What Determines Resilience in Patients with Parkinson's Disease?
04:00 PM - 07:00 PM Abstract 147 - Decision-Making Profile of Parkinson's Disease Patients with Pathological Gambling
04:00 PM - 07:00 PM Abstract 148 - Acamprosate Improves Impulse Control Disorders in Parkinson's Disease
04:00 PM - 07:00 PM Abstract 149 - Topiramate in Managing Impulse Control Disorders in Parkinson's Disease
04:00 PM - 07:00 PM Abstract 150 - Craving for Sweets and Other Compulsive Behaviors in Patients with Parkinson's Disease
04:00 PM - 07:00 PM Abstract 151 - Mild Parkinsonian Signs Are Associated with Lower Olfactory Test Scores in the Community-Dwelling Elderly
04:00 PM - 07:00 PM Abstract 152 - Subjective Assessments Do Not Adequately Evaluate Excessive Daytime Sleepiness in Parkinson's Disease
04:00 PM - 07:00 PM Abstract 153 - Unique Relationship between Apathy and P3 Response in Parkinson's Disease
04:00 PM - 07:00 PM Abstract 154 - Optimizing Algorithms To Identify Idiopathic Parkinson's Disease Cases within an Administrative Database
04:00 PM - 07:00 PM Abstract 155 - Botulinum Toxin Type B Clinical Safety in Cervical Dystonia Following up to 4 Years of Treatment
04:00 PM - 07:00 PM Abstract 156 - Accelerometry: Variable Correlation with Functional Impact of Tremor
04:00 PM - 07:00 PM Abstract 157 - Cardiovascular Fitness and Cognition in Mild-Moderate Parkinson's Disease
04:00 PM - 07:00 PM Abstract 158 - Palatal Myoclonus: Three Key Points That Alert to Its Diagnosis
04:00 PM - 07:00 PM Abstract 159 - Tic Disorders in Musicians
04:00 PM - 07:00 PM Abstract 160 - Botulinum Toxin Type B (MYOBLOC) in Patients with Cervical Dystonia: An Open-Label Extension Study (AN072-402 EU/CD)
04:00 PM - 07:00 PM Abstract 161 - The G2019S LRRK2 Mutation in a Brazilian Cohort with Parkinson's Disease: Phenotype in Monozygotic Twins
04:00 PM - 07:00 PM Abstract 162 - Objective Assessment of Efficacy and Safety in Idiopathic RLS: Results from a 7-Week Sleep Lab Trial with the Transdermal Rotigotine Patch
04:00 PM - 07:00 PM Abstract 163 - Excessive Daytime Sleepiness in Idiopathic Restless Legs Syndrome: Characteristics and Evolution under Dopaminergic Treatment
04:00 PM - 07:00 PM Abstract 164 - Rapid Onset and Sustained Efficacy of Pramipexole in Restless Legs Syndrome
04:00 PM - 07:00 PM Abstract 165 - Effects of Pramipexole on Daytime Symptoms of Restless Legs Syndrome
04:00 PM - 07:00 PM Abstract 166 - Rapid Onset of Action and Sustained Efficacy of Pramipexole in RLS Patients with Mood Disturbance
04:00 PM - 07:00 PM Abstract 167 - Treatment of Daytime RLS Symptoms with Pramipexole in Patients with Mood Disturbance
04:00 PM - 07:00 PM Abstract 168 - Effect of Food on the Clinical Pharmacokinetics of XP13512
04:00 PM - 07:00 PM Abstract 169 - Clinical Pharmacokinetics of XP13512, a Novel Transported Prodrug of Gabapentin
04:00 PM - 07:00 PM Abstract 170 - The Association between Acute Cerebral Infarction and Restless Legs
04:00 PM - 07:00 PM Abstract 172 - Pramipexole for Restless Legs Syndrome and Associated Sleep Disturbance
04:00 PM - 07:00 PM Abstract 173 - Pramipexole for the Treatment of RLS and Associated Depressive Symptoms
04:00 PM - 07:00 PM Abstract 174 - Restless Legs Syndrome and Periodic Leg Movement Disorder Following Multiple Blood Donations
04:00 PM - 07:00 PM Abstract 175 - Pramipexole Improves Restless Legs Syndrome in a Pediatric Patient
04:00 PM - 07:00 PM Abstract 176 - Clinical Pharmacokinetic Drug-Interaction Studies of XP13512, a Novel Transported Prodrug of Gabapentin, with Naproxen and Cimetidine
04:00 PM - 07:00 PM Abstract 177 - Clinical Pharmacokinetics of XP13512, a Novel Transported Prodrug of Gabapentin, at Supratherapeutic Doses
04:00 PM - 07:00 PM Abstract 178 - Pregabalin Treatment Effects: Correlations of Sleep Diaries with Medical Outcomes Sleep Scale (MOS-SS) in Fibromyalgia (FM) Patients in Two Studies
04:00 PM - 07:00 PM Abstract 179 - Phase I/Pharmacokinetic Study of Enzastaurin Plus Temozolomide during and Following Radiation Therapy in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM) or Gliosarcoma (GS)
04:00 PM - 07:00 PM Abstract 180 - A Phase Ib Study of AdV-tk + Valacyclovir Gene Therapy in Combination with Standard Radiation Therapy for Patients with Malignant Glioma
04:00 PM - 07:00 PM Abstract 181 - Epilepsy and Brain Tumors: Frequency and Medical Therapy
04:00 PM - 07:00 PM Abstract 182 - The Role of Surgical Resection for Seizure Control in Primary and Metastatic Brain Tumors: A Retrospective Study
04:00 PM - 07:00 PM Abstract 183 - Bevacizumab in Recurrent Glioblastoma Multiforme
04:00 PM - 07:00 PM Abstract 184 - Bevacizumab Appears Active Against Recurrent Glioblastoma Multiforme: A Case Series
04:00 PM - 07:00 PM Abstract 185 - Asian Patients with Glioblastoma
04:00 PM - 07:00 PM Abstract 187 - Anaplastic Oligodendroglioma in Turcot Syndrome: Molecular Analysis and Review of the Literature
04:00 PM - 07:00 PM Abstract 188 - Ewing's Sarcoma Family Tumors Mimicking Primary Central Nervous System Neoplasms
04:00 PM - 07:00 PM Abstract 189 - CSF Study in Paraneoplastic Syndromes
04:00 PM - 07:00 PM Abstract 190 - Uptake of Anti-Yo Antibody Is Followed by Purkinje Cell Death in Organotypic Cultures: Implications for the Pathogenesis of Paraneoplastic Cerebellar Degeneration
04:00 PM - 07:00 PM Abstract 191 - Immunomediated Limbic Encephalitis: Clinical and Immunological Description of 15 Patients
04:00 PM - 07:00 PM Abstract 192 - Do Blood - Brain Barrier Breakdown Serum Markers Have Clinical Significance in Patients with Onconeuronal Antibodies?
04:00 PM - 07:00 PM Abstract 193 - Epidemiology, Neurological Phenotypes and Tumour Associations in a Series of 51 Non-Selected Patients with Serologically Confirmed Diagnosis of Paraneoplastic Neurological Syndrome
04:00 PM - 07:00 PM Abstract 194 - The Effects of Cerebellar Degeneration on Spatial Orientation Disturbances in Rats with Experimental Neoplastic Disease
04:00 PM - 07:00 PM Abstract 195 - Reversible Posterior Leukoencephalopathy Syndrome Following the Administration of Bevacizumab for Colon Cancer Metastatic to the Liver
04:00 PM - 07:00 PM Abstract 197 - Role of Greater Occipital Nerve Injections for Patients with Dizziness and Headache
04:00 PM - 07:00 PM Abstract 198 - Follow Up Investigation of Balance in Migraineurs
04:00 PM - 07:00 PM Abstract 199 - Clinical Features and Disability of Migraine and Probable Migraine by Age
04:00 PM - 07:00 PM Abstract 200 - Familial Clustering of Migraine and Patent Foramen Ovale: Pilot Study and Genetic Perspectives in a Population Isolate
05:30 PM - 07:00 PM Break
Faculty Disclosures
Sean J. Pittock, MD, FAAN Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Marcelo Matiello, MD, FAAN Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Matiello has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for WoltersKluwer.
Albert K. Akpalu, MD Dr. Akpalu has nothing to disclose.
No disclosure on file
Mingxin Tang, PhD No disclosure on file
Bruce L. Miller, MD, FAAN Dr. Miller has nothing to disclose.
John P. Hooge, MD No disclosure on file
Joseph F. Quinn, MD, FAAN Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Disease Cooperative Study. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Therapeutic Research Institute. Dr. Quinn has a non-compensated relationship as a consultant with Cognition Therapeutics that is relevant to AAN interests or activities.
Kunihiko Asakura, MD, PhD No disclosure on file
Allen J. Aksamit, Jr., MD, FAAN Dr. Aksamit has nothing to disclose.
Frederic Blanc No disclosure on file
Christiane Reitz, MD, PhD No disclosure on file
Olaf Stuve, MD, PhD, FAAN Dr. Stuve has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurological Diseases. Dr. Stuve has received research support from US Department of Veterans Affairs. Dr. Stuve has received research support from National Multiple Sclerosis Society (US). Dr. Stuve has received research support from Merck KGaA.
James E. Galvin, MD, MPH Dr. Galvin has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cognivue. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biogen. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eisai. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GE Healthcare. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Galvin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PassageBio. The institution of Dr. Galvin has received research support from National Institutes of Health. Dr. Galvin has received intellectual property interests from a discovery or technology relating to health care. Dr. Galvin has a non-compensated relationship as a Board of Directors with Alzheimer Association Southeast Florida Chapter that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Association that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Resource Center that is relevant to AAN interests or activities.
Lisa L. Barnes, PhD Lisa L. Barnes has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer's & Dementia. The institution of Lisa L. Barnes has received research support from NIH. Lisa L. Barnes has received personal compensation in the range of $500-$4,999 for serving as a Council member with NACMHD.
Sun Ju Chung, MD, PhD, FAAN Dr. Chung has nothing to disclose.
Lawrence S. Honig, MD, PhD, FAAN Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Honig has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. Dr. Honig has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Dr. Honig has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms . The institution of Dr. Honig has received research support from Roche. The institution of Dr. Honig has received research support from Eisau. Dr. Honig has received research support from Alector. The institution of Dr. Honig has received research support from Transposon.
Helene Zephir Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BIogen Idec. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BMS. Helene Zephir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Barry S. Oken, MD, PhD, FAAN Dr. Oken has nothing to disclose.
Martin J. Taphoorn, MD No disclosure on file
Kan Ding, MD The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS.
Maria Morais No disclosure on file
Maria P. Amato, PhD Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOU Careggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi genzyme. The institution of Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene BMS. The institution of Dr. Amato has received research support from Merck. The institution of Dr. Amato has received research support from Biogen. The institution of Dr. Amato has received research support from Roche.
Olivier F. Gout, MD Dr. Gout has nothing to disclose.
Andres M. Villa, MD Dr. Villa has nothing to disclose.
John C. Morris, MD, FAAN Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CBR International Advisory Board. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cure Alzheimers Fund. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LEADS Steering Commitee. The institution of Dr. Morris has received research support from NIH grants. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care.
Richard P. Mayeux, MD, MSc, FAAN Dr. Mayeux has nothing to disclose.
Paul M. Thompson, PhD No disclosure on file
Avindra Nath, MD, MBBS, FAAN The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care.
Claudia F. Lucchinetti, MD, FAAN The institution of Dr. Lucchinetti has received research support from Biogen Idec. The institution of Dr. Lucchinetti has received research support from NIH/NINDS. The institution of Dr. Lucchinetti has received research support from National Institute of Neurological Disorders and Stroke . The institution of Dr. Lucchinetti has received research support from National Multiple Sclerosis Society. The institution of Dr. Lucchinetti has received research support from National Center for Advancing Translational Sciences. Dr. Lucchinetti has received intellectual property interests from a discovery or technology relating to health care. Dr. Lucchinetti has a non-compensated relationship as a Member with National Institute of Neurological Disorders that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Board of Directors, Association of University Professors of Neurology that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Trustees that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Governors that is relevant to AAN interests or activities.
Soraya P. Da Silva, MD No disclosure on file
Sandra Vukusic, MD The institution of Dr. Vukusic has received research support from Biogen. The institution of Dr. Vukusic has received research support from Janssen. The institution of Dr. Vukusic has received research support from Merck. The institution of Dr. Vukusic has received research support from Novartis. The institution of Dr. Vukusic has received research support from Roche.
Norman Putzki, MD No disclosure on file
Petra Schicklmaier, PhD No disclosure on file
Nathan P. Young, DO Dr. Young has nothing to disclose.
Hans-Peter Hartung, MD, FAAN Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Jagarlapudi M. Murthy, MD, FAAN Dr. Murthy has nothing to disclose.
Kenneth Cundy, PhD No disclosure on file
Ricardo F. Allegri, MD, PhD, FAAN Dr. Allegri has nothing to disclose.
John N. Caviness, MD, FAAN Dr. Caviness has nothing to disclose.
Paul S. Fishman, MD, PhD No disclosure on file
Jody Corey-Bloom, MD, PhD, FAAN Dr. Corey-Bloom has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure. Dr. Corey-Bloom has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticaks. Dr. Corey-Bloom has received personal compensation in the range of $10,000-$49,999 for serving as a Co-Director, HD-Net with Huntington Study Group.
Ryan T. Merrell, MD No disclosure on file
Liana Apostolova, MD, FAAN Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for siemens. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Apostolova has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Association. The institution of Dr. Apostolova has received research support from Roche Diagnostics. The institution of Dr. Apostolova has received research support from NIA. The institution of Dr. Apostolova has received research support from Alzheimer Association. The institution of Dr. Apostolova has received research support from AVID radiopharmaceuticals. The institution of Dr. Apostolova has received research support from Life Molecular Imaging. Dr. Apostolova has a non-compensated relationship as a advisor with FDA that is relevant to AAN interests or activities.
Marcel Hungs, MD, PhD, FAAN No disclosure on file
Nicolaas I. Bohnen, MD, PhD, FAAN Dr. Bohnen has stock in Delta. The institution of Dr. Bohnen has received research support from NIH. The institution of Dr. Bohnen has received research support from VA. Dr. Bohnen has received research support from NIH. The institution of Dr. Bohnen has received research support from Parkinson fnd.
Serkan Ozakbas, MD Dr. Ozakbas has nothing to disclose.
Dhimant Dani, MD Dr. Dani has nothing to disclose.
Ralf Gold, MD Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
German Latorre No disclosure on file
Malco D. Rossi, MD Dr. Rossi has nothing to disclose.
Valerie E. Wojna, MD, FAAN Dr. Wojna has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Puerto Rico Health Sciences Journal, University of Puerto Rico Medical Sciences Campus. The institution of Dr. Wojna has received research support from NIH.
Richard J. Lederman, MD, PhD, FAAN No disclosure on file
Amitav Rath, Sr., MD No disclosure on file
Malgorzata Siger No disclosure on file
Angelo Ghezzi, MD No disclosure on file
Eduardo S. Tolosa, MD Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prevail. Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MSD . Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie . Dr. Tolosa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ever Neuropharm. Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Esteve. The institution of Dr. Tolosa has received research support from Instituto de Salud CArlos III. Dr. Tolosa has received research support from MJFF. Dr. Tolosa has received publishing royalties from a publication relating to health care.
Lindsey E. Kirsch Darrow No disclosure on file
Benzi Kluger, MD, FAAN Dr. Kluger has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for International Neuropalliative Care Society. Dr. Kluger has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Palliative Medicine. The institution of Dr. Kluger has received research support from NIH. The institution of Dr. Kluger has received research support from PCORI.
Renato P. Munhoz, MD, PhD Dr. Munhoz has nothing to disclose.
Werner Poewe, MD Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to AAN interests or activities.
Frederique Bouyx Etcharry, MD No disclosure on file
Melissa Armstrong, MD, MSc, FAAN, FAAN The institution of Dr. Armstrong has received research support from National Institutes of Health. The institution of Dr. Armstrong has received research support from Florida Department of Health. The institution of Dr. Armstrong has received research support from Lewy Body Dementia Association. The institution of Dr. Armstrong has received research support from The Michael J. Fox Foundation. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Clinical Trials Consortium. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Disease Cooperative Study. Dr. Armstrong has received personal compensation in the range of $500-$4,999 for serving as a DSMB member with National Institutes of Health. Dr. Armstrong has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Amrit Saxena No disclosure on file
Heinz Reichmann, MD, FAAN Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zambon. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wissenschaftsverlag.
Joseph Finkelstein No disclosure on file
Miri Y. Neufeld, MD No disclosure on file
Sophie Auriacombe Bergeaud, MD No disclosure on file
Alexandre Mackowiak, MD No disclosure on file
Catherine Larochelle, MD Dr. Larochelle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Novartis, Sanofi-Genzyme, Alexion, EMD-Serono, FIND therapeutics, Actelion. The institution of Dr. Larochelle has received research support from Université de Montréal-CHUM.
Elisabeth Wilde Elisabeth Wilde has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuropsychology. The institution of Elisabeth Wilde has received research support from CDMRP/DoD. The institution of Elisabeth Wilde has received research support from VA. The institution of Elisabeth Wilde has received research support from NIH. The institution of Elisabeth Wilde has received research support from Cohen Veteran Biosciences.
Thomas A. Berger, MD Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
Heike Benes No disclosure on file
Muhammad S. Hussain, MD Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiger Medical.
Tatsuro Misu No disclosure on file
Marie Fleury No disclosure on file
Dennis W. Dickson, MD Dr. Dickson has nothing to disclose.
Amos D. Korczyn, MD Dr. Korczyn has nothing to disclose.
Guido Alves No disclosure on file
Gulden Akdal, MD Dr. Akdal has nothing to disclose.
Mark W. Jacobson, PhD No disclosure on file
Cecilia Serrano No disclosure on file
Elisa Merelli No disclosure on file
Wolfgang H. Oertel, MD, FAAN Dr. Oertel has received personal compensation for serving as an employee of ParkinsonFonds Deutschland. Dr. Oertel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IntraBio, UK. Dr. Oertel has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for MODAG Germany. The institution of Dr. Oertel has received research support from Stichting ParkinsonFonds, The Netherlands,. The institution of Dr. Oertel has received research support from Michael J Fox Foundation.
Serge Mrejen No disclosure on file
Howard J. Rosen, MD Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly . Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alector. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities.
William L. Hills, MD No disclosure on file
R. John Leigh, MD No disclosure on file
Edward M. Manno, MD, FAAN No disclosure on file
Alexandra Guevara No disclosure on file
Slawomir Michalak, PhD No disclosure on file
Diego Franciotta, MD Dr. Franciotta has nothing to disclose.
Steven Edland, MS No disclosure on file
Anu Jacob, MD Dr. Jacob has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ALEXION.
Carlos Singer, MD Dr. Singer has nothing to disclose.
Lisa M. Shulman, MD, FAAN The institution of Dr. Shulman has received research support from NIH. Dr. Shulman has received publishing royalties from a publication relating to health care. Dr. Shulman has received publishing royalties from a publication relating to health care.
Pasquale Montagna, MD No disclosure on file
Ignacio Casanova No disclosure on file
Teresa Frohman, PA No disclosure on file
Laura J. Balcer, MD, MSCE, FAAN An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Joseph E. Parisi, MD Dr. Parisi has nothing to disclose.
Abdul Malik, MD, FAAN No disclosure on file
Alain Destee, MD, PhD No disclosure on file
Ely S. Simon, MD No disclosure on file
Ulf Kallweit No disclosure on file
Nikolaos Scarmeas, MD, FAAN Dr. Scarmeas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Albert Einstein Collego of Medicine. The institution of Dr. Scarmeas has received research support from NovoNordisc. The institution of Dr. Scarmeas has received research support from European Union Horizon Projects. The institution of Dr. Scarmeas has received research support from Hellenic Foundation for Research & Innovation .
Regina Lam No disclosure on file
Akira Machida No disclosure on file
Anthony Schapira No disclosure on file
Galeno Rojas, MD No disclosure on file
Ronald Antulov No disclosure on file
Hassan Fathallah-Shaykh, MD No disclosure on file
Kazuo Fujihara, MD Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Boipharma. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Japan Tobacco. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Fujihara has received research support from Ministry of Health, Welfare and Labor of Japan. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Novartis. Dr. Fujihara has received personal compensation in the range of $5,000-$9,999 for serving as a speaker, chair, etc with Biogen. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a speaker, chair, etc with Mitsubishi-Tanabe. Dr. Fujihara has received personal compensation in the range of $10,000-$49,999 for serving as a apeaker, chair, etc with Chugai/Roche. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair, etc with Alexion. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a chair, speaker with Asahi Kasei Medical. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker with Eisai. Dr. Fujihara has received personal compensation in the range of $500-$4,999 for serving as a speaker, chair with Teijin.
Israel Steiner, MD No disclosure on file
Vanessa Troiani No disclosure on file
Alessandra Lugaresi, MD Dr. Lugaresi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Lugaresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis Pharma. Dr. Lugaresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Sqibb. Dr. Lugaresi has a non-compensated relationship as a Speaker at meetings, participant in trials with Fondazione Italiana Sclerosi Multipla that is relevant to AAN interests or activities.
Deborah Fontaine No disclosure on file
Brian Prunier No disclosure on file
Hubert H. Fernandez, MD, FAAN Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Kousuke Saito No disclosure on file
Ole-Bjorn Tysnes No disclosure on file
Carla Tortorella No disclosure on file
Karen Anderson No disclosure on file
Maia Tchikviladze, MD No disclosure on file
Nikita Tangella No disclosure on file
Fernando Taragano No disclosure on file
Keith A. Johnson, MD Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NervGen. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oligomerix. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AC Immune. The institution of Dr. Johnson has received research support from National Institute on Aging. The institution of an immediate family member of Dr. Johnson has received research support from Alzheimer's Association. The institution of an immediate family member of Dr. Johnson has received research support from Eli Lilly and Co. The institution of Dr. Johnson has received research support from Eisai. The institution of an immediate family member of Dr. Johnson has received research support from Eisai.
Markku Partinen, MD, PhD, FAAN No disclosure on file
Merry Chen, MD Dr. Chen has nothing to disclose.
Barbara E. Shapiro, MD, PhD No disclosure on file
Dan M. Mungas, PhD Dr. Mungas has nothing to disclose.
Jeffrey A. Cohen, MD, FAAN Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for DOJ. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for gross minsky mogul. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Ratcliffe Harten Galalmaga . Dr. Cohen has received publishing royalties from a publication relating to health care.
Jonathan L. Carter, MD Dr. Carter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck Pharmaceuticals A/S. The institution of Dr. Carter has received research support from MedDay Pharmaceuticals . The institution of Dr. Carter has received research support from Roche Pharmaceuticals.
Stephen N. Gomperts, MD, PhD, FAAN Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EIP. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cowen. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bob's Last Stand. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Focus Boston. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Expert connect. Dr. Gomperts has received personal compensation in the range of $0-$499 for serving as a Consultant for Mosaic. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jannsen. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from LBDA. The institution of Dr. Gomperts has received research support from DOD/CDMRP. The institution of Dr. Gomperts has received research support from FFFPRI. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from MJFF. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from MJFF. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from NIH. Dr. Gomperts has received intellectual property interests from a discovery or technology relating to health care.
Robin A. Conwit, MD, FAAN Dr. Conwit has nothing to disclose.
Ronald J. Tusa, MD, PhD No disclosure on file
Dean M. Wingerchuk, MD, FAAN Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers.
Charles S. DeCarli, MD, FAAN Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. DeCarli has received research support from NIH.
Daniel A. Nation, PhD Dr. Nation has nothing to disclose.
Ayman P. Tourbah No disclosure on file
Edgar F. Salazar-Grueso, MD No disclosure on file
Brendan J. Kelley, MD, FAAN Dr. Kelley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Labcorp. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai.
Elliot M. Frohman, MD, FAAN Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
Xinyue Qin No disclosure on file
Marcos R. De Freitas, MD, PhD No disclosure on file
Alister J. Prout, MD No disclosure on file
Gregory A. Jicha, MD, PhD Dr. Jicha has nothing to disclose.
Luigi Ferini-Strambi, MD Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bioprojet. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for lundbeck. Dr. Ferini-Strambi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for idorsia. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Italfarmaco. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bruno Farmaceutici. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Sleep Medicine.
David A. Bennett, MD Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annovis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for New Amsterdam. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie.
Glen R. Finney, MD, FAAN Dr. Finney has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Premier Inc. Dr. Finney has a non-compensated relationship as a Board Member with Greater Pennsylvania Chapter of the Alzheimer's Association that is relevant to AAN interests or activities.
Amer Malik, MD Dr. Malik has nothing to disclose.
Ola A. Selnes, PhD No disclosure on file
Christian Confavreux, MD No disclosure on file
Ramon C. Leiguarda, MD No disclosure on file
Carole Bellegarde Sereni, MD No disclosure on file
Kinya Ishikawa, MD, PhD Dr. Ishikawa has nothing to disclose.
Charlotte Crinquette No disclosure on file
Dag Aarsland, MD Dr. Aarsland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics.
Bernhard Hemmer, MD No disclosure on file
Joseph Hentz No disclosure on file
Thomas Beach Thomas Beach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivid Genomics. Thomas Beach has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. The institution of Thomas Beach has received research support from National Institutes of Health. The institution of Thomas Beach has received research support from Michael J Fox Foundation . The institution of Thomas Beach has received research support from State of Arizona.
Christine Farag No disclosure on file
Patrick Hautecoeur No disclosure on file
Claire Meyniel, MD No disclosure on file
Celine Chayer, MD No disclosure on file
Paolo Barone, MD No disclosure on file
Amber Salter, PhD Dr. Salter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gryphon Bio. Dr. Salter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abata Therapeutics. Dr. Salter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sora Neuroscience. Dr. Salter has stock in Owl Therapeutics. The institution of Dr. Salter has received research support from National Multiple Sclerosis Society. The institution of Dr. Salter has received research support from Department of Defense Congressionally Directed Medical Research Program. The institution of Dr. Salter has received research support from Consortium of Multiple Sclerosis Centers.
Mouhammad A. Jumaa, MD Dr. Jumaa has nothing to disclose.
Meng C. Wong, MBBS, MMed, FAAN No disclosure on file
Bonnie E. Levin, PhD No disclosure on file
Ana Escribano No disclosure on file
Bradley J. Robottom, MD No disclosure on file
Eliezer Masliah, MD Dr. Masliah has nothing to disclose.
Ayesha Sherzai, MD No disclosure on file
Judith E. Warner, MD Dr. Warner has received intellectual property interests from a discovery or technology relating to health care.
Neill R. Graff-Radford, MD, FAAN The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
William J. Weiner, MD No disclosure on file
Alan H. Yee, DO Dr. Yee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janux Therapeutics. The institution of Dr. Yee has received research support from American Osteopathic Association .
Amilton A. Barreira, MD No disclosure on file
Danyella Dogini, PhD No disclosure on file
Anne Caroline Papeix No disclosure on file
Roberto D. Rey, MD Dr. Rey has nothing to disclose.
Michal Szulc No disclosure on file
Matthew Rizzo, MD, FAAN The institution of Dr. Rizzo has received research support from NIH.
Robert L. Rodnitzky, MD, FAAN No disclosure on file
Gary R. Cutter, PhD Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Sarah H. Ying, MD Dr. Ying has nothing to disclose.
Stefano Bastianello No disclosure on file
Gordon T. Plant No disclosure on file
Massimiliano M. Siccoli, MD No disclosure on file
Satyanarayana Gedela, MD Dr. Gedela has nothing to disclose.
Tania F. Tayah, MD, FAAN Dr. Tayah has nothing to disclose.
Carlos A. Luciano, MD, FAAN Dr. Luciano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for SIMED. Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Vazquez-Irizarry Law Office. The institution of Dr. Luciano has received research support from National Institutes of Health. Dr. Luciano has received personal compensation in the range of $100,000-$499,999 for serving as a Professor and Chair with University of Puerto Rico.
Angela Vincent, MBBS, MSc Angela Vincent, MBBS, MSc has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Lundbeck Foundation. Angela Vincent, MBBS, MSc has received intellectual property interests from a discovery or technology relating to health care.
Zoe Arvanitakis, MD, MS, FAAN Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc.. Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Dementia. Dr. Arvanitakis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for a private legal firm representing a governemental entity. The institution of Dr. Arvanitakis has received research support from National Institutes of Health (NIH). Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with The National Institutes of Health and California State (California Institute for Regenerative Medicine or CIRM). Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant and Educator with Summus Global, Inc.
Theresa A. Zesiewicz, MD Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lexeo. Dr. Zesiewicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Steminent. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Gerald Pfeffer, MD, PhD Dr. Pfeffer has received research support from Canadian Institutes of Health Research.
Brett J. Theeler, MD, FAAN Dr. Theeler has nothing to disclose.
Joshua Mekler, MD No disclosure on file
Anna Czlonkowska, MD Dr. Czlonkowska has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Alexion.
Kristina Gartzen No disclosure on file
Eric P. Baron, DO Dr. Baron has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharmaceuticals, Inc.. Dr. Baron has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck, LLC. Dr. Baron has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven Pharmaceuticals. Dr. Baron has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Inc.. Dr. Baron has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel Pharmaceuticals, Inc.. Dr. Baron has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck, LLC. Dr. Baron has received publishing royalties from a publication relating to health care.
Robert A. Hauser, MD, MBA, FAAN Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
William W. Seeley, MD Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Council. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global Consulting. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BridgeBio. Dr. Seeley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Seeley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lyterian Therapeutics. The institution of Dr. Seeley has received research support from NIH. The institution of Dr. Seeley has received research support from Rainwater Charitable Foundation. The institution of Dr. Seeley has received research support from Bluefield Project to Cure FTD. The institution of Dr. Seeley has received research support from Chan-Zuckerberg Initiative.
Richard L. Skolasky, BA No disclosure on file
Jan Mares, MD Dr. Mares has nothing to disclose.
Kerstin Hellwig Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from BMS .
Dina Jacobs, MD Dr. Jacobs has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck/EMD Serono. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharmaceuticals. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi . Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for William Blair &Company . Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi . The institution of Dr. Jacobs has received research support from Roche/Genentech .
Wael Richeh, MD Dr. Richeh has nothing to disclose.
Claudio L. Bassetti, MD No disclosure on file
Olivier Rascol, MD, PhD Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL. Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MEDIZIN ACADEMY. The institution of Dr. Rascol has received research support from Agence Nationale de la Recherche (ANR), CHU de Toulouse, France-Parkinson, INSERM-DHOS Recherche Clinique Translationnelle, MJFox Foundation, Programme Hospitalier de Recherche Clinique, European Commission (FP7, H2020).
Maria Trojano Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi_Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Dawn Bowers, PhD No disclosure on file
Karen Wetzel, MPAS, PA-C No disclosure on file
Ahmed Hassan, MD No disclosure on file
James F. Burke, MD Dr. Burke has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association/Circulation: Cardiovascular quality and outcomes. The institution of Dr. Burke has received research support from Genentech Foundation. The institution of Dr. Burke has received research support from NIH.
Fani Andelman, PhD No disclosure on file
Morris Freedman, MD, FAAN No disclosure on file
Ritu Lal, PhD No disclosure on file
John Houben, PharmD No disclosure on file
Jonathan Rosand, MD Dr. Rosand has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Rosand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Rosand has received research support from NIH. The institution of Dr. Rosand has received research support from American Heart Association. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as a Peer reviewer with National Institutes of Health. Dr. Rosand has a non-compensated relationship as a Trustee with Columbia University that is relevant to AAN interests or activities.
Ramon L. Rodriguez Cruz, MD, FAAN The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus . The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyoway Kirin. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Rodriguez Cruz has received research support from Cerevance. The institution of Dr. Rodriguez Cruz has received research support from Neuraly. The institution of Dr. Rodriguez Cruz has received research support from Amneal. The institution of Dr. Rodriguez Cruz has received research support from Teva. The institution of Dr. Rodriguez Cruz has received research support from Neurocrine. Dr. Rodriguez Cruz has received publishing royalties from a publication relating to health care.
Michael S. Okun, MD, FAAN Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Robert Zivadinov, MD, PhD, FAAN The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Holly A. Shill, MD, FAAN Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeifeRx. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicine. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl Inc. Dr. Shill has received personal compensation in the range of $0-$499 for serving as a Consultant for Boston Scientific. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America.
Petr Kanovsky, PhD Dr. Kanovsky has nothing to disclose.
Pierre Labauge, MD Dr. Labauge has nothing to disclose.
Paolo Livrea No disclosure on file
Murray Grossman, MD, FAAN Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Richard Kryscio No disclosure on file
Giovanni B. Zimatore, MD No disclosure on file
Adriane Mayda No disclosure on file
Carlos Lopez De Silanes No disclosure on file
Bradley J. Katz, MD, PhD Bradley J. Katz, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for axon optics, LLC. Bradley J. Katz, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for self employed. Bradley J. Katz, MD, PhD has received stock or an ownership interest from Pfizer. Bradley J. Katz, MD, PhD has received intellectual property interests from a discovery or technology relating to health care.
Reisa A. Sperling, MD Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acumen. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nervgen. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oligomerix. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vaxxinity. An immediate family member of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. An immediate family member of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Sperling has received research support from Eli Lilly. The institution of Dr. Sperling has received research support from Eisai. The institution of Dr. Sperling has received research support from NIH.
Stephen G. Reich, MD, FAAN Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
Ergun Y. Uc, MD An immediate family member of Dr. Uc has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Board of Pediatrics. The institution of Dr. Uc has received research support from Department of Veterans Affairs. The institution of Dr. Uc has received research support from Department of Defense. The institution of an immediate family member of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from Parkinson's Foundation. The institution of Dr. Uc has received research support from NIH.
Carmen R. Fuentes-Rodriguez, MD No disclosure on file
Ann Gruber-Baldini No disclosure on file
Rana Assouad, MD No disclosure on file
Vittorio Cosi No disclosure on file
Kathleen B. Digre, MD, FAAN Dr. Digre has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Headache Society. The institution of Dr. Digre has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuro-ophthalmology. The institution of Dr. Digre has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Utah Womens Health Review. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received publishing royalties from a publication relating to health care. Dr. Digre has received publishing royalties from a publication relating to health care.
Brian G. Weinshenker, MD, FAAN Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care.
Alexander Zubkov, MD, PhD, FAHA No disclosure on file
Bruce R. Reed, PhD No disclosure on file
Spyridon Papapetropoulos, MD, PhD Dr. Papapetropoulos has received personal compensation for serving as an employee of Vigil Neuroscience . Dr. Papapetropoulos has received personal compensation for serving as an employee of Bionomics Ltd. Dr. Papapetropoulos has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Lipocine Inc. Dr. Papapetropoulos has stock in Vigil Neuroscience. Dr. Papapetropoulos has stock in Lipocine. Dr. Papapetropoulos has stock in Bionomics Ltd.
Siew Ju See, MBBS No disclosure on file
Jesus Porta No disclosure on file
Bertrand Fontaine, MD No disclosure on file
Alessandra Persico, MD No disclosure on file
Mark Keegan, MD, FAAN Dr. Keegan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Keegan has received publishing royalties from a publication relating to health care. Dr. Keegan has received publishing royalties from a publication relating to health care.
Dean Sherzai, MD, PhD, MAS No disclosure on file
Elizabeth A. Shuster, MD No disclosure on file
Jorge G. Burneo, MD, MSPH, FAAN Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, Clinical Neurology and Neurosurgery Journal. Dr. Burneo has received research support from The Jack Cowin Endowed Chair in Epilepsy Research. Dr. Burneo has received publishing royalties from a publication relating to health care. Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Jazz Pharmaceuticals.
Romain Marignier, MD, PhD Dr. Marignier has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALEXION. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE.
Kelly Sullivan, PhD Dr. Sullivan has received intellectual property interests from a discovery or technology relating to health care.
Pradeep K. Sahota, MD, FAAN The institution of Dr. Sahota has received research support from VA Merit award.
Marcelo Merello No disclosure on file
Shanu Roemer Shanu Roemer has nothing to disclose.
Gil D. Rabinovici, MD, FAAN Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Norodisk. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for C2N. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Joihnson. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Peerview. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA. The institution of Dr. Rabinovici has received research support from NIH. The institution of Dr. Rabinovici has received research support from American College of Radiology. The institution of Dr. Rabinovici has received research support from Alzheimer's Association. The institution of Dr. Rabinovici has received research support from Rainwater Charitable Foundation. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Topic Chair, Course Director and teacher with AAN. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with ANA.
Robert Y. Moore, MD, FAAN No disclosure on file
Debbie Yam No disclosure on file
Jose L. Ruiz-Sandoval, MD Dr. Ruiz-Sandoval has nothing to disclose.
Steven Galetta, MD, FAAN Dr. Galetta has nothing to disclose.
Jaesung Kim, MD No disclosure on file
Alexandra Flowers, MD No disclosure on file
Clyde E. Markowitz, MD No disclosure on file
Jean Francois Chermann No disclosure on file
Akintomi A. Olugbodi, MD No disclosure on file
Taiji Tsunemi, MD, PhD No disclosure on file
Keith Vossel, MD No disclosure on file
Cintia Marchesoni, MD Cintia Marchesoni, MD has nothing to disclose.
George H. Kraft, MD No disclosure on file
Alessia Di Sapio, MD No disclosure on file
Masharip Atadzhanov, MD, PhD, DSc, FRCP, FAAN Dr. Atadzhanov has nothing to disclose.
Carlo S. Tornatore, MD Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serono. Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Ryan Hays, MD, MBA, FAES, FAAN Dr. Hays has nothing to disclose.
David Blihar, MD No disclosure on file
Peter P. Pramstaller, MD No disclosure on file
Hidehiro Mizusawa, MD, PhD No disclosure on file
Eloi Magnin No disclosure on file
Ana M. Pardal, MD No disclosure on file
Irene Pichler No disclosure on file
Perla C. Thulin, MD Dr. Thulin has nothing to disclose.
Maurizio Facheris, MD, MSc Dr. Facheris has received personal compensation for serving as an employee of Vanqua Bio. Dr. Facheris has stock in Vanqua Bio.
Derya Kaya No disclosure on file
Clementine Karageorgiou, MD The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for GENESIS PHARMA. The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA-SPECIFAR.
Laxman Bahroo, DO, FAAN Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Bahroo has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ipsen. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. Dr. Bahroo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Bahroo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie. Dr. Bahroo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Acorda. Dr. Bahroo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amneal. Dr. Bahroo has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Bahroo has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Neurocrine. Dr. Bahroo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Bahroo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lundbeck. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merz.
Daniel M. Canafax, PharmD No disclosure on file
Russell E. Bartt, MD, FAAN Dr. Bartt has nothing to disclose.
Grant Liu, MD, FAAN Dr. Liu has received publishing royalties from a publication relating to health care.
Ricardo C. Reisin, MD Dr. Reisin has nothing to disclose.
Dimitri Psimaras, MD No disclosure on file
Michael L. Reed, PhD The institution of Dr. Reed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Reed has received research support from Allergan. The institution of Dr. Reed has received research support from Dr Reddy's Labs/Promius. The institution of Dr. Reed has received research support from Allay Lamp. Dr. Reed has a non-compensated relationship as a Research Analyst with National Headache Foundation that is relevant to AAN interests or activities.
Bernadette Kalman, MD, PhD, Dsc, FAAN, FAAN No disclosure on file
Simona Malucchi No disclosure on file
Antonio Uccelli, MD An immediate family member of Dr. Uccelli has received personal compensation for serving as an employee of Biogen. The institution of Dr. Uccelli has received research support from Merck. The institution of Dr. Uccelli has received research support from Roche.
Maria Luisa Gorno Tempini, MD, PhD The institution of Dr. Gorno Tempini has received research support from the NIH.
Antoine F. Carpentier No disclosure on file
Amy E. Sanders, MD, FAAN Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Adlarity. Dr. Sanders has a non-compensated relationship as a Medical and Scientific Advisory Board with Alzheimer's Association (CT Chapter) that is relevant to AAN interests or activities. Dr. Sanders has a non-compensated relationship as a Board Member with UCNS that is relevant to AAN interests or activities.
Petr Hlustik, MD, PhD The institution of Prof. Hlustik has received research support from Czech Health Research Council (AZV CR).
Michael H. Pfeiffer, MD, PhD No disclosure on file
Gordon J. Chelune, PhD The institution of an immediate family member of Dr. Chelune has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor & Francis. Dr. Chelune has stock in Centruy Therapeutics, Inc. The institution of Dr. Chelune has received research support from NIA. Dr. Chelune has received intellectual property interests from a discovery or technology relating to health care. Dr. Chelune has received publishing royalties from a publication relating to health care.
Norman L. Foster, MD, FAAN No disclosure on file
Marcelo E. Bigal, MD, PhD No disclosure on file
Joe Verghese, MD, FAAN Dr. Verghese has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedRhythms Inc. The institution of Dr. Verghese has received research support from National Institutes of Health.
Lucien Rumbach, MD No disclosure on file
Rudolf Schoenhuber, MD, MBA No disclosure on file
John E. Greenlee, MD, FAAN Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Zeigler Cohen Roche. Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sommers Schwartz PC. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for St Francis Hospital. Dr. Greenlee has received publishing royalties from a publication relating to health care. Dr. Greenlee has received publishing royalties from a publication relating to health care.
Cynthia L. Comella, MD, FAAN Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care.
Francesca Gilli No disclosure on file
Jordan Grafman, PhD Dr. Grafman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Grafman has received research support from NIH. Dr. Grafman has received publishing royalties from a publication relating to health care.
Tristen Moors, MS No disclosure on file
Marco Capobianco, MD No disclosure on file
John Papatriantafyllou, MD Dr. Papatriantafyllou has nothing to disclose.
Mieczystaw B. Wender, MD, PhD No disclosure on file
John D. Steffens, MD Dr. Steffens has nothing to disclose.
Cecilia M. Shikuma, MD No disclosure on file
Chiara La Morgia, MD Dr. La Morgia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Regulatory Pharmanet s.r.l. . Dr. La Morgia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Santhera Pharmaceuticals. Dr. La Morgia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chiesi Farmaceutici s.p.a.. The institution of Dr. La Morgia has received research support from Italian Ministry of Health.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Daniah Shamim, MD Dr. Shamim has nothing to disclose.
Lonni Schultz, PhD Dr. Schultz has nothing to disclose.
Muhtadi Islam, MD No disclosure on file
Roberta Vitaliani, MD No disclosure on file
Olivier Felician No disclosure on file
Stanton B. Elias, MD No disclosure on file
Katherine P. Rankin, PhD The institution of Dr. Rankin has received research support from Marcus Foundation.
Nicholas Szumski, MD No disclosure on file
Sven O. Jarius, MD Dr. Jarius has nothing to disclose.
Ahmad M. Al-Sabbagh, MD Dr. Al-Sabbagh has nothing to disclose.
Bruno Giometto, MD Dr. Giometto has nothing to disclose.
Joseph Jankovic, MD, FAAN Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Eric M. Cheng, MD, MS, FAAN Dr. Cheng has received research support from Dr. Heather Nelson-Brantley.
Tamara Vyshkina, PhD No disclosure on file
Seung B. Hong, MD No disclosure on file
Herman Buschke, MD No disclosure on file
suzanne stevens, MD Dr. Stevens has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Stevens has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Harmony Biosciences. Dr. Stevens has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Inspire Medical.
Antonio Bertolotto, MD, FAAN Dr. Bertolotto has nothing to disclose.
Krystin C. Baker, MD No disclosure on file
Wojciech Kozubski, MD, PhD No disclosure on file
Brian Grosberg, MD Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma pharmaceuticals. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Theranica . Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Grosberg has stock in Theranica. The institution of Dr. Grosberg has received research support from Theranica. The institution of Dr. Grosberg has received research support from Amgen. The institution of Dr. Grosberg has received research support from Abbvie. The institution of Dr. Grosberg has received research support from Eli Lilly. The institution of Dr. Grosberg has received research support from Teva. The institution of Dr. Grosberg has received research support from Neurolief. Dr. Grosberg has received publishing royalties from a publication relating to health care.
Aaron McMurtray, MD, FAAN The institution of an immediate family member of Dr. McMurtray has received research support from US Government . An immediate family member of Dr. McMurtray has received intellectual property interests from a discovery or technology relating to health care. Dr. McMurtray has received personal compensation in the range of $100,000-$499,999 for serving as a Panel member with Legal Firm.
Antoine Moulignier, MD No disclosure on file
Kenneth Hill No disclosure on file
Takeshi Matsuoka No disclosure on file
Vesile Ozturk, MD No disclosure on file
Luigi Zuliani No disclosure on file
Erdem Tuzun Erdem Tuzun has nothing to disclose.
Neil Cherian, MD Dr. Cherian has nothing to disclose.
Edward Huey No disclosure on file
Janis Daly, MS PhD No disclosure on file
Thomas J. Grabowski, MD The institution of Dr. Grabowski has received research support from NIH.
Eric J. Pappert, MD No disclosure on file
Anand Trip, MD No disclosure on file
Orhun H. Kantarci, MD Dr. Kantarci has nothing to disclose.
Michele K. York, PhD, ABPP-CN Dr. York has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for RAD-PD. The institution of Dr. York has received research support from Michael J. Fox Foundation. The institution of Dr. York has received research support from NIH. The institution of Dr. York has received research support from Takeda.
Joseph H. Friedman, MD, FAAN No disclosure on file
Lisa M. Bateman, MD, FRCPC The institution of Dr. Bateman has received research support from NIH/NINDS.
Robert Cavaliere, MD No disclosure on file
Hendrikus G. Krouwer, MD, PhD No disclosure on file
Roger G. Mills, MD No disclosure on file
Juline Bryson, MD Dr. Bryson has received personal compensation for serving as an employee of Teva Pharmaceuticals. Dr. Bryson has or had stock in Teva .
Carlos Romero No disclosure on file
Takuya Matsushita No disclosure on file
Janet C. Rucker, MD Dr. Rucker has nothing to disclose.
Paul R. Carney, MD No disclosure on file
Rachel J. Saunders-Pullman, MD The institution of Dr. Saunders-Pullman has received research support from NIH, Bigglesworth Family Foundation, Empire Clinical Research Investigatory Program.
Karen S. Marder, MD, MPH, FAAN Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Marder has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Foundation . Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CHDI. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC therapeutics. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer LTD. The institution of Dr. Marder has received research support from Vaccinex. The institution of Dr. Marder has received research support from Genentech. The institution of Dr. Marder has received research support from Triplet Therapeutics. The institution of Dr. Marder has received research support from Prilenia.
Molly Zimmerman No disclosure on file
Margaret Park, MD No disclosure on file
Claudio Solaro, MD No disclosure on file
Panagiotis Zikos, MD No disclosure on file
Angeli Mayadev, MD Dr. Mayadev has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Mayadev has received research support from Ipsen.
Joohi Jimenez Shahed, MD, FAAN Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BlueRock. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Treefrog. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RebrAIn. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueRock Therapeutics. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PhotoPharmics. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. The institution of Dr. Jimenez Shahed has received research support from Amneal. The institution of Dr. Jimenez Shahed has received research support from Annovis. The institution of Dr. Jimenez Shahed has received research support from SAGE. The institution of Dr. Jimenez Shahed has received research support from Ono Pharmaceuticals. The institution of Dr. Jimenez Shahed has received research support from BlueRock. The institution of Dr. Jimenez Shahed has received research support from Neuron23. Dr. Jimenez Shahed has received personal compensation in the range of $0-$499 for serving as a Faculty with Movement Disorders Society. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with 好色先生. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Parkinson Foundation.
James D. Geyer, MD No disclosure on file
Sergio I. Valdes-Ferrer, MD, PhD No disclosure on file
Noel Carlson, PhD The institution of Mr. Carlson has received research support from Biogen. Mr. Carlson has received personal compensation in the range of $100,000-$499,999 for serving as a Employee as a Researcher with Veteran Affairs.
Dennis Meletiche No disclosure on file
Christof Karmonik, PhD No disclosure on file
Domingo O. Garcea, MD No disclosure on file
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
David H. Miller, MD, MBChB, FRCP No disclosure on file
Warren Darling No disclosure on file
Arthur Kramer No disclosure on file
William T. Hu, MD, PhD, FAAN Dr. Hu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fujirebio. Dr. Hu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman Coulter. Dr. Hu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apellis Pharmaceuticals. The institution of Dr. Hu has received research support from NIA. The institution of Dr. Hu has received research support from TMCity Foundation. The institution of Dr. Hu has received research support from Atlanta Family Foundation. The institution of Dr. Hu has received research support from Fujirebio Diagnostics.
Catherine Lubetzki Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK SERONO. Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for REWIND.
Christine B. Hunter, RN, BSN No disclosure on file
Micaela Robotti, MD No disclosure on file
Dorene M. Rentz, PsyD Dr. Rentz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Digital Cognition Technologies. Dr. Rentz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurotrack.
Stacey Cofield No disclosure on file
Victor Valcour, MD Dr. Valcour has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for IAS-USA. Dr. Valcour has received personal compensation in the range of $500-$4,999 for serving as a reviewer with NIH.
Mathieu Ceccaldi, MD No disclosure on file
Mirela Cerghet, MD, PhD, FAAN Dr. Cerghet has nothing to disclose.
Zuhal Yapici, MD Dr. Yapici has nothing to disclose.
Giovanni Crespi No disclosure on file
Chris M. Kozma No disclosure on file
Edward Keller No disclosure on file
Constantine Lyketsos Constantine Lyketsos has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Avanir, Karuna, Maplight, Axsome, GW Research Limited, Merck, EXCIVA GmbH, Otsuka, IntraCellular Therapies, Medesis, BMS, IQVIA. Constantine Lyketsos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. The institution of Constantine Lyketsos has received research support from NIA. Constantine Lyketsos has received publishing royalties from a publication relating to health care. Constantine Lyketsos has received publishing royalties from a publication relating to health care.
Ana Piera Blabastre No disclosure on file
Dennis J. Dlugos, MD Dr. Dlugos has received research support from NIH. The institution of Dr. Dlugos has received research support from The Epilepsy Study Consortium.
Elan D. Louis, MD, MS, FAAN Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer - Merritt's Textbook of Neurology. Dr. Louis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Firm. The institution of Dr. Louis has received research support from National Institutes of Health. Dr. Louis has received publishing royalties from a publication relating to health care. Dr. Louis has a non-compensated relationship as a Board of Directors with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Louis has a non-compensated relationship as a Medical Advisory Board with HopeNET that is relevant to AAN interests or activities.
Ilia Itin, MD No disclosure on file
Jean A. Jaglin, RN No disclosure on file
Uri Napchan, MD No disclosure on file
Jun-ichi Kira, MD, PhD Dr. Kira has nothing to disclose.
Miguel J. Lainez, MD, PhD, FAAN No disclosure on file
Mefkure Eraksoy, MD Dr. Eraksoy has nothing to disclose.
Valerio Carelli, MD, PhD Dr. Carelli has received personal compensation in the range of $0-$499 for serving as a Consultant for Chiesi Farmaceutici. Dr. Carelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi Farmaceutici.
Patrizia Amati-Bonneau No disclosure on file
Camilo R. Gomez, MD, FAAN Dr. Gomez has nothing to disclose.
Randy Bennett No disclosure on file
Christopher Power, MD Dr. Power has nothing to disclose.
Fred D. Lublin, MD, FAAN Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Robert C. Green, MD, MPH No disclosure on file
Joachim M. Baehring, MD, FAAN Dr. Baehring has nothing to disclose.
Sarah Farias No disclosure on file
Steven W. Anderson, PhD Dr. Anderson has nothing to disclose.
Anette E. Schrag, MD Dr. Schrag has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Otsuka. Dr. Schrag has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz. Dr. Schrag has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer ingelheim. Dr. Schrag has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. The institution of Dr. Schrag has received research support from NIHR, EU, Parkinson's UK, MDS.
Dulara Hussain, MD No disclosure on file
Roberto Bergamaschi Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Andrew Henderson, MD Dr. Henderson has nothing to disclose.
Anil K. Nair, MD, FAAN No disclosure on file
Romila Mushtaq, MD No disclosure on file
Jeffrey Dawson Jeffrey Dawson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for iotaMotion. Jeffrey Dawson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Congress of Neurological Surgeons. The institution of Jeffrey Dawson has received research support from Department of Veterans Affairs. The institution of Jeffrey Dawson has received research support from NIH.
Pamela Z. New, MD, FAAN No disclosure on file
E. A. Chiocca, MD, PhD No disclosure on file
Robert Stern, PhD Robert Stern, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Robert Stern, PhD has received research support from Eisai. The institution of Robert Stern, PhD has received research support from Lilly. The institution of Robert Stern, PhD has received research support from ATRI/NIA. Robert Stern, PhD has received publishing royalties from a publication relating to health care. Robert Stern, PhD has a non-compensated relationship as a Member with NFLPA Mackey-White Committee that is relevant to AAN interests or activities.
Christopher Goetz, MD, FAAN The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
Jeffrey A. Kaye, MD, FAAN Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care.
Kazumasa Yokoyama, MD No disclosure on file
Rui Pedrosa, MD No disclosure on file
Helio Afonso G. Teive, MD, PhD, FAAN Dr. Teive has nothing to disclose.
Ruta Verchovsky No disclosure on file
Jean-Francois Dartigues, PhD No disclosure on file
Jan P. Larsen No disclosure on file
Guerry M. Peavy, PhD Dr. Peavy has stock in MRK. Dr. Peavy has stock in ABT. Dr. Peavy has stock in JNJ. Dr. Peavy has stock in ABBV. The institution of an immediate family member of Dr. Peavy has received research support from NIH. The institution of Dr. Peavy has received research support from NIH.
Stephanie Lessig, MD No disclosure on file
Ed Whalen Ed Whalen has received personal compensation for serving as an employee of Pfizer. Ed Whalen has stock in Pfizer.
Nicholas A. Butowski, MD No disclosure on file
Vassilis E. Koliatsos, MD No disclosure on file
Andre Maues De Paula, MD, PhD No disclosure on file
Florian Deisenhammer, MD Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Deisenhammer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/Celgene. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Almirall. Dr. Deisenhammer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celgene. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Deisenhammer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SOBI.
Irene Malaty, MD, FAAN Dr. Malaty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aevum. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. The institution of Dr. Malaty has received research support from Acadia. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to AAN interests or activities.
Jerry S. Wolinsky, MD, FAAN Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Mark Agius, MD No disclosure on file
Raquel Gardner, MD Dr. Gardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BrainBox. The institution of Dr. Gardner has received research support from NIH. The institution of Dr. Gardner has received research support from DoD.
Joel J. Oger, MD, FRCPC, FAAN No disclosure on file
Patrick Vermersch Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Joel Kline No disclosure on file
Heather Katzen, PhD Dr. Katzen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Adult Hydrocephalus Clinical Research Network. Dr. Katzen has received publishing royalties from a publication relating to health care.
Sean P. Morrissey, MD No disclosure on file
Bruno Stankoff, MD, PhD The institution of Bruno Stankoff, MD, PhD has received research support from Roche, Sanofi, Serono . The institution of Bruno Stankoff, MD, PhD has received research support from Novartis.
William Birmingham No disclosure on file
Doralina G. Brum No disclosure on file
Rosalia C. Silvestri-Hobson, MD No disclosure on file
Fortunato Battaglia, MD Dr. Battaglia has nothing to disclose.
Harold R. Smith, MD, FAAN No disclosure on file
Jeffrey A. Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Francisco J. Carod-Artal, MD, FAAN Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyers. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Dr. Carod-Artal has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Meyers Squip. Dr. Carod-Artal has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merz. Dr. Carod-Artal has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Charles H. Adler, MD, PhD, FAAN Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Giovanni Castelnovo No disclosure on file
Lineu C. Werneck, MD No disclosure on file
Ashok Verma, MD, FAAN Dr. Verma has nothing to disclose.
Gorsev G. Yener, MD No disclosure on file
Elisabetta Di Monte No disclosure on file
Myoung C. Lee, MD, FAAN No disclosure on file
Maria C. Zurru, MD No disclosure on file
Juan R. Sanchez-Ramos, MD, PhD No disclosure on file
Matthew Kidd, DO No disclosure on file
Worthy R. Warnack, Jr., MD No disclosure on file
Felicia Goldstein No disclosure on file
James J. Lah, MD, PhD Dr. Lah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. The institution of Dr. Lah has received research support from Roche.
Hans J. Hansen, MD No disclosure on file
Joseph Herbert, MD No disclosure on file
Gene L. Bowman, ND No disclosure on file
Nicole Schupf, PhD, DrPH No disclosure on file
Mohammad Wasay, MBBS, FAAN Dr. Wasay has nothing to disclose.
Olivier Outteryck Olivier Outteryck has nothing to disclose.
Eliana Roldan Gerschovich No disclosure on file
Maria A. Amengual, MD No disclosure on file
Allan I. Levey, MD, PhD Dr. Levey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genuv. Dr. Levey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cognito Therapeutics. Dr. Levey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Levey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Karuna Pharmaceuticals. Dr. Levey has received stock or an ownership interest from NextSense. The institution of Dr. Levey has received research support from NIH. The institution of Dr. Levey has received research support from Biogen. The institution of Dr. Levey has received research support from Esai. The institution of Dr. Levey has received research support from AAN. The institution of Dr. Levey has received research support from State of Georgia. The institution of Dr. Levey has received research support from Novartis. The institution of Dr. Levey has received research support from Genentech. Dr. Levey has received intellectual property interests from a discovery or technology relating to health care. Dr. Levey has received personal compensation in the range of $500-$4,999 for serving as a NAPA Avisory Committee Co-Chair with US Dept of Health and Human Services.
Thor Petersen No disclosure on file
Deepika Nemani No disclosure on file
Marla E. Jordan-Gonzalez, MD No disclosure on file
L C. Pettigrew, MD, MPH, FAAN No disclosure on file
Yaakov Stern, PhD Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Stern has received intellectual property interests from a discovery or technology relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Erwin Chiquete, MD, PhD No disclosure on file
Jennifer L. Cox, PhD Dr. Cox has nothing to disclose.
Gloria Von Geldern, MD, FAAN The institution of Dr. Von Geldern has received research support from Novartis. The institution of Dr. Von Geldern has received research support from Contineum Therapeutics. Dr. Von Geldern has received personal compensation in the range of $0-$499 for serving as a DSMB member with NIH, NINDS. Dr. Von Geldern has a non-compensated relationship as a editorial board member with MS and Related Disorders Journal that is relevant to AAN interests or activities.
Yoshiro Ohara, MD No disclosure on file
Austen P. Moore No disclosure on file
William Martens William Martens has nothing to disclose.
Matthew L. Ho, MD No disclosure on file
Francesco Patti, MD Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Almirall. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Almirall, Bayer, Biogen, Bristol Meyers and Squibb Merck, Roche, Sanofi, TEVA. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for University of Catania and AISM/FISM, Fondazione Italiana Sclerosi Multipla. Dr. Patti has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Juan C. Troncoso, MD No disclosure on file
Judith Stephenson No disclosure on file
William R. Markesbery, MD No disclosure on file
Peter A. Calabresi, MD, FAAN Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Christopher Ward No disclosure on file
Roger N. Rosenberg, MD, FAAN No disclosure on file
Jae-Hong Lee, MD No disclosure on file
Charles J. Vecht, MD, PhD, FAAN No disclosure on file
Glen M. Doniger, PhD No disclosure on file
Justin C. McArthur, MBBS, MPH, FAAN No disclosure on file
Francois G. Kamar, MD No disclosure on file
Avi A. Algom, MD No disclosure on file
Robert A. Bermel, MD, FAAN Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
I. Jon Russell No disclosure on file
Marwan N. Sabbagh, MD, FAAN Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Yuko Shimizu, MD, PhD Dr. Shimizu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen Japan.. Dr. Shimizu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis Pharma. Dr. Shimizu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chigai Pharma CoLtd.
Randall L. Woltjer Randall L. Woltjer has nothing to disclose.
Sudha R. Gupta, MD, MBBS No disclosure on file
Armando Sena, MD, PhD No disclosure on file
Turi Dalaker No disclosure on file
Ken Uchino, MD Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aboott Laboratories, Inc.. Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACP JOURNAL CLUB. The institution of Dr. Uchino has received research support from NIH.
Jeannette A. Barrett, PhD No disclosure on file
Ebrima Gibbs, Bsc, BMLSc, MSc Dr. Gibbs has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Promis Neurosciences.
Sung-Min Kim, MD No disclosure on file
Qi Li, MD, PhD No disclosure on file
Johannes Jakobsen, MD, DMSci The institution of Dr. Jakobsen has received research support from TAKEDA. Dr. Jakobsen has received publishing royalties from a publication relating to health care. Dr. Jakobsen has received personal compensation in the range of $5,000-$9,999 for serving as a Advisor with Danish Medicine Counsil.
Jose Luchsinger-Stuart No disclosure on file
Joseph Staffetti, MD Joseph Staffetti has nothing to disclose.
Pedro Bermejo, MD No disclosure on file
Alexandre Kreisler No disclosure on file
Gabriele Niemczyk, MD No disclosure on file
Egon Stenager, MD No disclosure on file
Amy Conger No disclosure on file
Nivia Hernandez-Ramos, MD No disclosure on file
Paolo F. Nichelli, MD No disclosure on file
Melissa W. Ko, MD, FAAN Dr. Ko has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Ko has received research support from HRSA. Dr. Ko has received research support from IU Health.
Jeanette Farina, MD No disclosure on file
Kaili Stanley No disclosure on file
Giovanna Zamboni, MD Dr. Zamboni has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eli Lilly . The institution of Dr. Zamboni has received research support from European Research Council.
Daniel McConnell No disclosure on file
Jennifer McCombe, MD Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon therapeutics. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon therapeutics.
Masud Seyal, MD, PhD, FAAN Dr. Seyal has nothing to disclose.
Mark G. Malkin, MD, FAAN Dr. Malkin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Worldwide Clinical Trials. Dr. Malkin has received publishing royalties from a publication relating to health care.
Stephen Revell, MD No disclosure on file
Alan M. Mandell, MD No disclosure on file
Christine Cooper, MD Dr. Cooper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Cooper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Cooper has received research support from Biogen. The institution of Dr. Cooper has received research support from Abbvie. The institution of Dr. Cooper has received research support from NIH.
Til Menge, MD, FAAN No disclosure on file
Jennifer Connelly, MD No disclosure on file
Sharon Polensek, MD, PhD No disclosure on file
Tariq M. Aziz No disclosure on file
Sanford H. Auerbach, MD, FAAN Dr. Auerbach has nothing to disclose.
Natalia Llanes, MD No disclosure on file
Jeffrey L. Cummings, MD, FAAN Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia, Actinogen, Acumen, AlphaCognition, ALZpath, Aprinoia, AriBio, Artery, Biogen, Biohaven, BioVie, BioXcel, Bristol-Myers Squib, Cassava, Cerecin, Diadem, Eisai, GAP Foundation, GemVax, Janssen, Jocasta, Karuna, Lighthouse, Lilly, Lundbeck, LSP/eqt, Mangrove Therapeutics, Merck, NervGen, New Amsterdam, Novo Nordisk, Oligomerix, ONO, Optoceutics, Otsuka, Oxford Brain Diagnostics, Prothena, ReMYND, Roche, Sage Therapeutics, Signant Health, Simcere, sinaptica, Suven, TrueBinding, Vaxxinity, and Wren pharmaceutical, assessment, and investment companies. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia, Biogen, Genentech, Grifols, Janssen, Karuna, Otsuka, reMYND, Roche, Signant Health. Dr. Cummings has stock in Artery, Vaxxinity, Behrens, Alzheon, MedAvante-Prophase, and Acumen. Dr. Cummings has received research support from NIH. Dr. Cummings has received research support from NIGMS. Dr. Cummings has received intellectual property interests from a discovery or technology relating to health care.
Patrick Waters, PhD Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UBC. The institution of Dr. Waters has received research support from Guthy-Jackson Charitable Foundation. Dr. Waters has received intellectual property interests from a discovery or technology relating to health care.
Ralf Kohnen, PhD, ScD No disclosure on file
Rahmeen Farhoudi No disclosure on file
Krishna Mettu, MD No disclosure on file
Manjamalai Sivaraman, MD Dr. Sivaraman has nothing to disclose.
Yokota Takanori No disclosure on file
Kwang W. Lee, MD No disclosure on file
Carolina Leon Jimenez, MD No disclosure on file
Robert A. Egan, MD, FAAN No disclosure on file
Kurt Lindsay, MD No disclosure on file
Claudia Gneiss No disclosure on file
Francisco De Assis Gondim, MD, PhD, MSc, FAAN No disclosure on file
Claudia Trenkwalder, MD Dr. Trenkwalder has received personal compensation for serving as an employee of Paracelsus-Kliniken. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esteve. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Trenkwalder has received research support from DLR /BMBF. Dr. Trenkwalder has received intellectual property interests from a discovery or technology relating to health care.
Alban Millonig, MD, PhD No disclosure on file
Natasha Frost, MD, FAAN Dr. Frost has nothing to disclose.
Markus Reindl, PhD The institution of Dr. Reindl has received research support from Euroimmun. The institution of Dr. Reindl has received research support from Roche.
Karin C. Stiasny-Kolster, MD No disclosure on file
Scott Smith No disclosure on file
Kristy Hwang No disclosure on file
Gisele R. Oliveira, MD No disclosure on file
Hossein Ansari, MD, FAAN Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NOEMA Pharmaceutical . Dr. Ansari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BIOHAVEN Pharmaceutical . Dr. Ansari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioDelivery Sciences International, Inc. . Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie Pharmaceutical . Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen Pharmaceutical . Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven Pharmaceutical . Dr. Ansari has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Ansari has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck Pharmaceutical . Dr. Ansari has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceutical . Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for MedLegal Network. Dr. Ansari has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Litogation Legal insight ( LITILI). Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for FOLAND, WICKENS, ROPER, HOFER & CRAWFORD, P.C.
Santiago Pigretti No disclosure on file
Isma E. Velez-Fernandez, MD No disclosure on file
Christopher Commichau, MD, FAAN No disclosure on file
Pavel Hok, MD Dr. Hok has nothing to disclose.
Teri R. Thomsen, MD Dr. Thomsen has nothing to disclose.
Kathrin Husmann, MD No disclosure on file
Aline Herlopian, MD Dr. Herlopian has nothing to disclose.
Paolo Preziosa Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Alessandro Meani Alessandro Meani has nothing to disclose.
Harry Chugani, MD No disclosure on file
Angeliki Vgontzas, MD Dr. Vgontzas has nothing to disclose.
Issam Awad, MD No disclosure on file
Nikita Dedhia, MD No disclosure on file
Philip Skidd, MD Dr. Skidd has nothing to disclose.
Monika H. Adamczyk-Sowa, MD, PhD No disclosure on file
Luis Cunha, PhD No disclosure on file
Kevin R. Blauth, PhD No disclosure on file
Penny Eames, MD No disclosure on file
William W. Pendlebury, MD No disclosure on file
Waqar Waheed, MD, MBBS Dr. Waheed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB.
Zachary Miller, MD Dr. Miller has nothing to disclose.
Shirish M. Hastak, MD No disclosure on file
Anita Tipirneni, MD No disclosure on file
Adam Andrzey Niezgoda No disclosure on file
Daniel Schonhaut No disclosure on file
Alessandro Biffi, MD Dr. Biffi has received personal compensation for serving as an employee of Eli Lilly And Company. Dr. Biffi has stock in Eli Lilly And Company.
Raffaella Chieffo, MD No disclosure on file
Amy Akers, MD No disclosure on file
Lalitha Vaithianathar No disclosure on file
Tania J. Rebeiz, MD Dr. Rebeiz has nothing to disclose.
Slawomir Wawrzyniak No disclosure on file
Abdul Ghani Mikati, MD No disclosure on file
Husnu Efendi, MD The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alexion. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Roche. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Novartis.
Brianne Bettcher No disclosure on file
Alina Kulakowska No disclosure on file
Yasir M. Malik, Sr., MD No disclosure on file
Megan Donohue, MD Dr. Donohue has nothing to disclose.
Rebecca M. Kuenzler, MD No disclosure on file
Abubaker Almadani, MD No disclosure on file
Olajide A. Williams, MD Dr. Williams has nothing to disclose.
Muhammad F. Suri, MD Dr. Suri has nothing to disclose.
Salman Al Jerdi, MD Dr. Al Jerdi has nothing to disclose.
Laura E. Baldassari, MD, MHS No disclosure on file
Dorota Koziarska No disclosure on file
Raja B. Khan, MD, FAAN Dr. Khan has nothing to disclose.
Allison Kaup No disclosure on file
Rohan Arora, MD The institution of Dr. Arora has received research support from Bayer.
Michelle Voss No disclosure on file
Jacek Losy, MD, PhD No disclosure on file
Richard Libman, MD, FAAN Dr. Libman has nothing to disclose.
Ivo W. Tremont, MD, FAAN Dr. Tremont has nothing to disclose.
Claire E. Carrazco, DO No disclosure on file
Susan W. Law, DO Dr. Law has nothing to disclose.
Aashit K. Shah, MD, FAAN Dr. Shah has stock in Abbot, Abbivie, Gilead, Johnson and Johnson, Pfizer. The institution of Dr. Shah has received research support from Xenon Pharma.
Dolora R. Wisco, MD Dr. Wisco has nothing to disclose.
Mohamad Ezzeldin, MD Dr. Ezzeldin has nothing to disclose.
Paul Wright, MD, FAAN Dr. Wright has nothing to disclose.
Sita J. Sattaluri Dr. Sattaluri has nothing to disclose.
Javeed A. Dar, MD No disclosure on file
Edip M. Gurol, MD The institution of Dr. Gurol has received research support from NIH/NINDS. The institution of Dr. Gurol has received research support from Boston Scientific Corporation. The institution of Dr. Gurol has received research support from AVID (a wholly owned subsidiary of Eli Lilly). The institution of Dr. Gurol has received research support from Pfizer.
Betul B. Gundogdu, MD Dr. Gundogdu has nothing to disclose.
Zsila Sadighi, MD No disclosure on file
Katherine D. Holland, MD, PhD No disclosure on file
Geetha Chari, MD, FAAN Dr. Chari has nothing to disclose.
Umair Saeed, MD No disclosure on file
Allan M. Glanzman, PT Mr. Glanzman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Mr. Glanzman has received intellectual property interests from a discovery or technology relating to health care.
Ravindra Arya The institution of Ravindra Arya has received research support from National Institutes of Health. The institution of Ravindra Arya has received research support from Cincinnati Children's Research Foundation.
Eero Rissanen, MD Dr. Rissanen has received research support from Sigrid Juselius Foundation.
Sammy D. Pishanidar, MD No disclosure on file
Syed F. Zaidi, MD Dr. Zaidi has nothing to disclose.
Rocio Hernandez Clares, MD, PhD No disclosure on file
Mark Agostini, MD Dr. Agostini has nothing to disclose.
Anthony Kwan No disclosure on file
Danuta Nocon No disclosure on file
Rodica Di Lorenzo, MD Dr. Di Lorenzo has nothing to disclose.
Sara K. Rostanski, MD Dr. Rostanski has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Individual law firms.
Alyssa M. Murphy No disclosure on file
Shahriar Zehtabchi No disclosure on file
Pournamy Sarathchandran, MD, MBBS, PhD, FAAN No disclosure on file
David Mendez No disclosure on file
Husnain Hashim, MBBS No disclosure on file
Maysaa M. Basha, MD, FAAN Dr. Basha has nothing to disclose.
Mohammed A. ElSherif, MD, PhD, FAAN Dr. ElSherif has nothing to disclose.
Matthew B. Freeman, MD No disclosure on file
Bilal Butt, MD Dr. Butt has nothing to disclose.
Giorgia Querin, MD No disclosure on file
Massimiliano Copetti No disclosure on file
David Bearden, MD Dr. Bearden has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bearden has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Bearden has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for law firms.
Abdulradha Alqallaf, MD Dr. Alqallaf has nothing to disclose.
Navid Seraji-Bozorgzad, MD No disclosure on file
Karl Deisseroth, MD No disclosure on file
Divyanshu Dubey, MD, FAAN The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
Seby John, MD Dr. John has nothing to disclose.
Ram N. Narayan, MD, FAAN Dr. Narayan has nothing to disclose.
Hisham Salahuddin, MD Dr. Salahuddin has nothing to disclose.
Cristiane R. Afonso, MD No disclosure on file
Jihad S. Inshasi, MD, MBBS, FAAN Dr. Inshasi has nothing to disclose.
Thomas V. Kodankandath, MD, FAAN Dr. Kodankandath has nothing to disclose.
Hossam M. Egila, MD No disclosure on file
Hansel Greiner, MD No disclosure on file
Robert K. Mannel, MD No disclosure on file
Fidel Meira, MD No disclosure on file
Pilar Maria Ferraro, PhD No disclosure on file
Rachel Salazar, PT No disclosure on file
Przemyslaw Nowacki No disclosure on file
Maria Cerdan Sanchez No disclosure on file
Tereza Svrcinova Tereza Svrcinova has nothing to disclose.
Zuzana Matejcikova No disclosure on file
Gianni Soraru No disclosure on file
Todd Masel, MD Dr. Masel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zeto Inc..
Clotilde Balucani, MD, PhD Dr. Balucani has nothing to disclose.
Narges Moghimi, MD Dr. Moghimi has nothing to disclose.
Nisha Giridharan No disclosure on file
Aida Orviz-García, MD Dr. Orviz-García has nothing to disclose.
Basit Rahim, MD No disclosure on file
Muhammad Ubaidulhaq, MD Dr. Ubaidulhaq has nothing to disclose.
Diego D. Dorim, MD No disclosure on file
Nadia Sotudeh, MD No disclosure on file
Advait Mahulikar, MD No disclosure on file
Pradeep Kumbham, MD Dr. Kumbham has nothing to disclose.
Devashish D. Ruikar, MD Dr. Ruikar has nothing to disclose.
Orwa Aboud, MD, PhD Dr. Aboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aboud LLC.
Tina Duong Tina Duong has received personal compensation for serving as an employee of Roche. Tina Duong has received personal compensation for serving as an employee of Novartis. Tina Duong has received personal compensation for serving as an employee of Scholar Rock. Tina Duong has received personal compensation for serving as an employee of Genentech. Tina Duong has received personal compensation for serving as an employee of Novartis. Tina Duong has received personal compensation for serving as an employee of Sarepta. Tina Duong has received personal compensation for serving as an employee of Biogen. Tina Duong has received personal compensation for serving as an employee of Audentes. Tina Duong has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Tina Duong has received personal compensation in the range of $0-$499 for serving as a Consultant for Audentes. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. The institution of Tina Duong has received research support from biogen. The institution of Tina Duong has received research support from scholar rock.
Ester Carreon Guarnizo Ester Carreon Guarnizo has nothing to disclose.
Caitlin White Dr. White has nothing to disclose.